血浆醛固酮浓度/血浆肾素浓度值诊断原发性醛固酮增多症
出处
《医学研究杂志》
2006年第7期82-83,共2页
Journal of Medical Research
参考文献4
-
1Young W F Jr. Primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinol, 2003, 144 : 2208 - 2213.
-
2李振华,孔垂泽,杨春明,王毅.原发性醛固酮增多症诊疗简史[J].中华医史杂志,2004,34(2):83-88. 被引量：2
-
3Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone - producing adenoma by measuring plasma renin activity. Arch Intern Med, 1981, 141 : 1589 - 1593.
-
4Montori V M, Young WF Jr. Use of plasma aldosterone concentration -to - plasma renin activity ratio as a screening test for primary aldosteronism. Endocrinol Metab Clin North Am, 2002, 31: 619- 32.
二级参考文献59
-
1Ganguly A, Grim CE, Bergstein J, et al. Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations. J Clin Endocrinol Metab, 1981, 53(5): 1040-1046.
-
2Ganong WF, van Brunt EE. Control of aldosterone secretion.Christy NP, Ganong WF, Greep RO, et al. The adrenocortical hormones. In: Eichler O, Farah A, Herken H, et al. Handbook of experimental pharmacology. Vol 14. New York: Springer-Verlag Inc. 1968,4-11
-
3Vaughan ED, Blumenfeld JD, Pizzo JD, et al. The adrenals. In:Walsh PC, Retik AB, Vaughan ED Jr, et al, eds. Campbell'sUrology, 8th, volume 4. Philadelphia: Saundes. 2002,3507-3569.
-
4Brodie AH, Shimizu N, Tait SA, et al. A method for the measurement of aldosterone in peripheral plasma using 3H-acetic anhydride. J Clin Endocrinol Metab, 1967, 27(7): 997-1011.
-
5Bayard F, Beitins IZ, Kowarski A, et al. Measurement of plasma aldosterone by radioimmunoassay. J Clin Endocrinol Metab, 1970,31(1):1-6.
-
6Conn JW, Rovner DR, Cohen EL. Normal and altered function of the rennin-angiotensin-aldosterone system in man. Ann Int Med, 1965, 63(2):266-284.
-
7Conn JW, Cohen EL, Rovner DR. Suppression of plasma renin activity in primary aldosteronism. JAMA, 1964:190(3):213-221.
-
8Conn JW. Plasma rennin activity in primary aldosteronism. Importance in differential diagnosis and in research of essential hypertension. JAMA, 1964,190(3) :222-231.
-
9Slaton PE, Biglieri EG. Hypertension and hyperaldosteronism of renal and adrenal origin. Am J Med, 1965, 38:324-336.
-
10Conn JW, Cohen EL, Rovner DR, et al. Normokalemic primary aldosteronism. A detectable cause of curable ""essential"" hypertension. JAMA, 1965, 193(3):200-206.
共引文献1
-
1邵晋康,王俊,杨艳兰,柳洁,姜焕荣,蔚锐传,郭琴,张乃珍,张三德.右侧醛固酮瘤并肾上腺髓质不规则增生一例[J].中华全科医师杂志,2006,5(4):254-255.
-
1孔垂泽,李振华.原发性醛固酮增多症的诊疗简史[J].继续医学教育,2006,20(11):12-17.
-
2陈金水,谢文艳,吴天敏,王华军,许昌声,黄友贞.复方丹参滴丸及其与福辛普利联用对自发性高血压大鼠左室肥厚的影响[J].中西医结合心脑血管病杂志,2004,2(12):718-720. 被引量：4
-
3陈丹丹,张弛,李华珠,杨晓春,周桂莲.甲亢合并系统性红斑狼疮1例[J].实用医学杂志,2010,26(15):2872-2873. 被引量：2
-
4蔡辉,李筝,焦东东,郭郡浩,郭寒.美托洛尔对充血性心力衰竭大鼠血浆醛固酮浓度、心肌纤维化和心室重构的影响[J].微循环学杂志,2010,20(1):13-15. 被引量：14
-
5李仙,黄志红.原发性醛固酮增多症外科治疗新进展[J].右江民族医学院学报,2014,36(1):87-89.
-
6邢卫红,张菊红,蒋文,欧阳玮瑾,成秋艳,张玉杰,李南方.高血压患者不同体位血浆醛固酮浓度与颈动脉粥样硬化的关系[J].中华高血压杂志,2012,20(4):358-362. 被引量：4
-
7邢卫红,李南方,张菊红,蒋文,欧阳玮琎,成秋艳,张玉洁,李变.45岁及以上高血压患者醛固酮与颈动脉粥样硬化关系研究[J].中国心血管杂志,2012,17(4):268-271. 被引量：3
-
8陈纯娴,吴可贵,王中心,杨芳,魏勇.原发性醛固酮增多症与高血压(附14例临床分析)[J].高血压杂志,2003,11(2):141-142. 被引量：12
-
9曾健,李南方,王新玲,祖菲娅,张德莲,常桂娟,周克明.影响原发性醛固酮增多症患者肾小球滤过率相关因素分析[J].中华全科医师杂志,2012,11(2):141-143.
-
10王新玲,张德莲,李南方,马兰,曾健,祖菲亚,常桂娟,努尔古丽,周克明,王国亮.原发性醛固酮增多症与原发性高血压患者颈动脉内中膜厚度的比较[J].医学研究杂志,2012,41(12):55-57. 被引量：1
